Towards Understanding the Pathogenesis of Rheumatic Fever

References

• Carapetis J R, Wolff D R, Currie B J. Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory. Med J Aust 1996; 164: 146–9
   PubMed Web of Science ®Google Scholar
• Markowitz M. Changing epidemiology of group A streptococcal infections. Pediatr Infect Dis J 1994; 13: 557–60
   PubMed Web of Science ®Google Scholar
• Stevens D L. Invasive group A streptococcal infections: the past, present and future. Pediatr Infect Dis J 1994; 13: 561–6
   PubMed Web of Science ®Google Scholar
• McCarty M. Theories of pathogenesis of streptococcal complications. Streptococci and streptococcal diseases, L W Wannamaker, J M Matsen. Academic Press, New York 1972; 517–26
   Google Scholar
• McCarty M. The role of immunological mechanisms in the pathogenesis of rheumatic fever. Streptococcal diseases and the immune response, S E Read, J B Zabriskie. Academic Press, New York 1980; 13–21
   Google Scholar
• Taranta A, Torosdag S, Metrakos J D, Jegier W, Uchida I. Rheumatic fever in monozygotic and dizygotic twins (abstract). Circulation 1959; 20: 778
   Web of Science ®Google Scholar
• Hafez M, Chakravarti A, El-Shennawy F, El-Morsi Z, El-Sallab S H, Al-Tonbary Y. HLA antigens and acute rheumatic fever: evidence for a recessive susceptibility gene linked to HLA. Genet Epidemiol 1985; 2: 273–82
   PubMedGoogle Scholar
• Khanna A K, Buskirk D R, Williams R C, Jr, et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest 1989; 83: 1710–6
   PubMed Web of Science ®Google Scholar
• Feldman B M, Zabriskie J B, Silverman E D, Laxer R M. Diagnostic use of B-cell alloantigen D8/17 in rheumatic chorea. J Pediatr 1993; 123: 84–6
   PubMedGoogle Scholar
• Guilherme L, Weidebach W, Kiss M H, Snitcowsky R, Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991; 83: 1995–8
   PubMed Web of Science ®Google Scholar
• Ayoub E M, Barrett D J, Maclaren N K, Krischer J P. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986; 77: 2019–26
   PubMed Web of Science ®Google Scholar
• Jhinghan B, Mehra N K, Reddy K S, Taneja V, Vaidya M C, Bhatia M L. HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease. Tissue Antigens 1986; 27: 172–8
   PubMedGoogle Scholar
• Patarroyo M E, Winchester R J, Vejerano A, et al. Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature 1979; 278: 173–4
   PubMed Web of Science ®Google Scholar
• Rammelkamp C H, Wannamaker L W, Denny F W. The epidemiology and prevention of rheumatic fever. Bull N Y Acad Med 1952; 28: 321–34
   PubMedGoogle Scholar
• Spagnuolo M, Pasternack B, Taranta A. Risk of rheumatic fever recurrences after streptococcal infections: prospective study of clinical and social factors. N Engl J Med 1971; 285: 641–7
   PubMed Web of Science ®Google Scholar
• Siegel A C, Johnson E E, Stollerman G H. Controlled studies of streptococcal pharyngitis in a pediatric population 1: Factors related to the attack rate of rheumatic fever. N Engl J Med 1961; 265: 559–66
   Google Scholar
• Kaplan E L. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. Circulation 1993; 88: 1964–72
   PubMedGoogle Scholar
• Kuttner A G, Krumweide E. Observations on the effect of streptococcal upper respiratory infections in rheumatic children: a three-year study. J Clin Invest 1941; 20: 273–87
   PubMedGoogle Scholar
• Stollerman G H. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol 1991; 61: 131–42
   PubMedGoogle Scholar
• Ayoub E M, Kaplan E L. Host-parasite interaction in the pathogenesis of rheumatic fever. J Rheumatol 1991; 18(Suppl 30)6–13
   Google Scholar
• Eichbaum Q G, Beatty D W, Parker M I. Identification of cardiac autoantigens in human heart DNA libraries using acute rheumatic fever sera. J Autoimmun 1994; 7: 243–61
   PubMedGoogle Scholar
• Bessen D, Jones K F, Fischetti V A. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 1989; 169: 269–283
   PubMedGoogle Scholar
• Martin D R, Voss L M, Walker S J, Lennon D. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J 1994; 13: 264–9
   PubMedGoogle Scholar
• Martin D R, Single L A. Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis 1993; 167: 1112–7
   PubMed Web of Science ®Google Scholar
• Bessen D E, Hollingshead S K. Allelic polymorphism of emm loci provides evidence for horizontal gene spread in group A streptococci. Proc Natl Acad Sci USA 1994; 91: 3280–41
   PubMedGoogle Scholar
• Carapetis J, Gardiner D, Currie B, Mathews J D. Multiple strains of Streptococcus pyogenes in skin sores of Aboriginal Australians. J Clin Microbiol 1995; 33: 1471–2
   PubMedGoogle Scholar
• Tran P OT, Johnson D R, Kaplan E L. The presence of M protein in nontypeable group A streptococcal upper respiratory tract isolates from Southeast Asia. J Infect Dis 1994; 169: 658–61
   PubMedGoogle Scholar
• Zabriskie J B. Rheumatic fever: a model for the pathological consequences of microbial-host mimicry. Clin Exp Rheumatol 1986; 4: 65–73
   PubMed Web of Science ®Google Scholar
• Taranta A, Markowitz M. Rheumatic fever. Kluwer Academic Publishers, Dordrecht 1989
   Google Scholar
• Kaplan M H. Rheumatic fever, rheumatic heart disease, and the streptococcal connection: the role of streptococcal antigens cross-reactive with heart tissue. Rev Infect Dis 1979; 1: 988–96
   PubMedGoogle Scholar
• Raizada V, Williams R Cc, Jr, Chopra P, et al. Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-Tcell antibodies. Am J Med 1983; 74: 90–6
   PubMed Web of Science ®Google Scholar
• Husby G, Arora R, Williams R C, Jr, Khaw B A, Harber E, Butler C. Immunofluorescence studies of florid rheumatic Aschoff lesions. Arthritis Rheum 1986; 29: 207–11
   PubMedGoogle Scholar
• Kemeny E, Grieve T, Marcus R, Sareli P, Zabriskie J B. Identification of mononuclear cells and Tcell subsets in rheumatic valvulitis. Clin Immunol Immunopathol 1989; 52: 225–37
   PubMedGoogle Scholar
• Samsonov M Y, Tilz G P, Pisklakov V P, et al. Serum-soluble receptors for tumor necrosis factor-a and interleukin-2, and neopterin in acute rheumatic fever. Clin Immunol Immunopathol 1995; 74: 31–4
   PubMedGoogle Scholar
• Kumar V, Ganguly N K, Anand I, Wahi S. PL. Release of oxygen free radicals by macrophages and neutrophils in patients with rheumatic fever. Eur Heart J 1991; 12(Suppl D)163–5
   PubMedGoogle Scholar
• Morris K, Mohan C, Wahi P L, Anand I S, Ganguly N K. Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study. Clin Exp Immunol 1993; 91: 429–36
   PubMed Web of Science ®Google Scholar
• Alarcon-Riquelme M E, Alarcon-Segovia D, Loredo-Abdala A, Alcocer-Varela J. T lymphocyte subsets, suppressor and contrasuppressor cell functions and production of interleukin-2 in the peripheral blood of rheumatic fever patients and their apparently healthy siblings. Clin Immunol Immunopathol 1990; 55: 120–8
   PubMedGoogle Scholar
• Read S E, Fischetti V A, Utermohlen V, Falk R E, Zabriskie J B. Cellular reactivity studies to streptococcal antigens. J Clin Invest 1974; 54: 439–50
   PubMedGoogle Scholar
• Pruksakorn S, Currie B, Brandt E, et al. Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int Immunol 1994; 6: 1235–44
   PubMed Web of Science ®Google Scholar
• Cromartie W J, Craddock J G. Rheumatic-like cardiac lesions in mice. Science 1966; 154: 285–7
   PubMed Web of Science ®Google Scholar
• DosReis G A, Gaspar M I, Barcinski M A. Immune recognition in the streptococcal carditis of mice: the role of macrophages in the generation of heart-reactive lymphocytes. J Immunol 1982; 128: 1514–21
   PubMedGoogle Scholar
• Schlievert P M. Role of superantigens in human disease. J Infect Dis 1993; 167: 997–1002
   PubMed Web of Science ®Google Scholar
• Schmidt K H, Gerlach D, Wollweber L, et al. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF. Infect Immun 1995; 63: 4569–75
   PubMedGoogle Scholar
• Kotb M. Infection and autoimmunity: a story of the host, the pathogen, and the copathogen. Clin Immunol Immunopathol 1995; 74: 10–22
   PubMedGoogle Scholar
• Dale J B, Chiang E Y, Lederer J W. Recombinant tetravalent group A streptotoccal M protein vaccine. J Immunol 1993; 151: 2188–2194
   PubMedGoogle Scholar
• Pruksakorn S, Currie B, Brandt E, et al. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet 1994; 344: 639–42
   PubMed Web of Science ®Google Scholar
• Bessen D, Fischetti V A. Synthetic peptide vaccine against mucosal colonization by group A streptococci: protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 1990; 145: 1251–6
   PubMed Web of Science ®Google Scholar
• Bronze M S, Courtney H S, Dale J B. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses. J Immunol 1992; 148: 888–93
   PubMed Web of Science ®Google Scholar
• Van Buynder P G, Gaggin J A, Martin D, Pugsley D, Mathews J D. Streptococcal infection and renal disease markers in Australian Aboriginal children. Med J Aust 1992; 156: 537–40
   PubMed Web of Science ®Google Scholar